跳至主要内容
临床试验/CTRI/2023/07/054644
CTRI/2023/07/054644尚未招募3 期

To study the effects of individualized homoeopathic treatment in rheumatoid arthritis sero positive and negative patients with NSAIDS by rheumatoid arthritis severity scale

oble Homoeopathic College and Research Institute0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Cases with Anti CCP above 20IU/ml or cases fulfilling the diagnostic criteria of rheumatoid arthritis.
  • Patients who had definite or classical RA, were seropositive for rheumatoid factor and were receiving either stable doses of single non-inflammatory drugs (NSAIDs) for more than 3 months or single disease-modifying anti-rheumatic drugs (DMARDs) with or without NSAIDs for more than 6 months.
  • Fully diagnosed case with adequate investigations

排除标准

  • Patients who were severely disabled, had taken systemic steroids in the previous 6 months or had withdrawn from DMARD therapy in the previous 12 months were excluded.

研究者

发起方
oble Homoeopathic College and Research Institute

相似试验